FDA Adverse Event Injury Summary report: N

CLARIFIX

MDR report key: 9046313 · Received September 13, 2019

Report

Report Number
3015132143-2019-00001
Event Type
Injury
Date Received
September 13, 2019
Date of Event
August 17, 2019
Report Date
September 13, 2019
Manufacturer
ARRINEX, INC
Product Code
GEH
PMA / PMN Number
K162608
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PHYSICIAN STATED THAT HE BELIEVES PATIENT'S PRE-EXISTING HYPERTENSION MAY HAVE CONTRIBUTED TO EXCESSIVE BLEEDING. AT THE TIME OF THIS REPORT, NO FURTHER PATIENT INJURY OR NEGATIVE HEALTH RELATED OUTCOMES HAVE BEEN REPORTED. THE DEVICE WAS DISCARDED AFTER THE PROCEDURE AND THE SERIAL NUMBER WAS NOT PROVIDE/UNKNOWN. THEREFORE, NO INVESTIGATION OF THE DEVICE WAS COMPLETED.

Description of Event or Problem · 1

MALE PATIENT RECEIVED BILATERAL CRYOTHERAPY IN THE NASAL PASSAGEWAY UNDER ENDOSCOPIC VISUALIZATION IN THE DOCTOR'S OFFICE ON (B)(6) 2019. UNKNOWN IF PATIENT FOLLOWED POST-TREATMENT INSTRUCTIONS. ON (B)(6) 2019, PATIENT PRESENTED WITH MAJOR EXSANGUINATING HEMORRHAGE FROM BOTH SIDES OF NASAL PASSAGEWAY AND HAD TO HAVE NASAL PACKING PLACED. ON (B)(6) 2019, PHYSICIAN REPORTED THAT PATIENT HAD INTERMITTENT BLEEDING WITH THE PACKING IN PLACE. PHYSICIAN INDICATED THAT HE WAS TAKING PATIENT TO OPERATING ROOM TO REMOVE THE NASAL PACK AND IF HE NOTED A DISTINCT BLEEDER, HE WOULD PERFORM ELECTROCAUTERIZE. HE FURTHER INDICATED HE WOULD HAVE A LOW THRESHOLD TO PERFORM SPHENOPALATINE ARTERY LIGATION. PHYSICIAN CONFIRMED ON 8/19/2019 THAT HE WAS UNABLE TO FIND AN ACTIVE BLEEDING SITE, BUT PERFORMED AN SPHENOPALATINE ARTERY LIGATION. ON 9/7/2019, PHYSICIAN PROVIDED ADDITIONAL INFORMATION THAT PATIENT HAD A HISTORY OF NOT PERFECTLY CONTROLLED BLOOD PRESSURE (E.G./ PATIENT WAS TAKING BLOOD PRESSURE MEDICINE BUT IT WAS APPARENT FROM DISCUSSION WITH ANESTHESIA THAT HE WAS SHOWING SIGNS OF BEING TOO HIGH ON THE FRONT END). PHYSICIAN BELIEVES A SCAB BROKE OFF AND BECAUSE OF HIS HIGH BLOOD PRESSURE HE CONTINUED TO BLEED FROM THE SPA AREA. DURING THE SURGERY HE COULD NOT SEE AN ACTIVE BLEEDING POINT THEREFORE HE FELT THE SPA LIGATION WAS NECESSARY IN ORDER TO ENSURE NO SUBSEQUENT BLEEDING. NO BLOOD TRANSFUSION REQUIRED. NO FURTHER PATIENT INJURY OR COMPLICATIONS. NO LONG-TERM CONSEQUENCES. PHYSICIAN STATED THAT HE BELIEVES PATIENT'S PRE-EXISTING HYPERTENSION MAY HAVE CONTRIBUTED TO EXCESSIVE BLEEDING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
820012 CLARIFIX CRYOABLATION DEVICE GEH ARRINEX, INC CFX-0001 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention